Literature DB >> 4522046

Metastatic spread of osteosarcoma.

C H Price, G M Jeffree.   

Abstract

A study is presented of the rate of metastatic spread of osteosarcoma. The series consists of 123 tumours in long bones and 26 elsewhere in the skeleton. All tumours occurred in otherwise normal bones and were histologically proven. With a few stated exceptions all the cases were consecutively registered.Both the mean disease-free interval from the time of starting treatment and the crude survival curves are given. The long bone cases are analysed by groups according to the method of treatment, the patient's sex, age and tumour site. There were too few tumours of all other sites to warrant this discriminative treatment. Whilst the results of surgical treatment are better than for radiotherapy or a combined technique, the differences are not statistically significant and the information is recorded primarily to assist the evaluation of new forms of treatment of occult and overt metastases. Some problems in connection with such clinical trials are discussed briefly.

Entities:  

Mesh:

Year:  1973        PMID: 4522046      PMCID: PMC2008946          DOI: 10.1038/bjc.1973.181

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  3 in total

1.  Recent advances in the chemotherapy of metastatic osteogenic sarcoma.

Authors:  N Jaffe
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

2.  Multiple pulmonary resections in the treatment of osteogenic sarcoma.

Authors:  N Martini; A G Huvos; V Miké; R C Marcove; E J Beattie
Journal:  Ann Thorac Surg       Date:  1971-09       Impact factor: 4.330

3.  Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases.

Authors:  R C Marcove; V Miké; J V Hajek; A G Levin; R V Hutter
Journal:  J Bone Joint Surg Am       Date:  1970-04       Impact factor: 5.284

  3 in total
  10 in total

1.  [Treatment and prognosis of osteosarcoma in childhood (author's transl)].

Authors:  M Salzer; M Salzer-Kuntschik; K Zhuber; C H Price; H G Willert; M Immenkamp; Z Matejovsky; P Groh; W Keyl
Journal:  Arch Orthop Unfallchir       Date:  1976-08-19

2.  Sclerotic medullary spread in diaphyseal osteosarcoma.

Authors:  J M Haworth; I W McCall; W M Park; I Watt
Journal:  Skeletal Radiol       Date:  1979       Impact factor: 2.199

3.  Osteosarcoma: the contribution of radiotherapy.

Authors:  G E Flatman
Journal:  Proc R Soc Med       Date:  1976-08

4.  [Diagnosis and treatment of bone tumors (author's transl)].

Authors:  H G Willert; A Enderle; G Fergenbauer
Journal:  Arch Orthop Unfallchir       Date:  1977-11-21

5.  Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

Authors:  A S Levin; V S Byers; H H Fudenberg; J Wybran; A J Hackett; J O Johnston; L E Spitler
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  The biology, pathology and immunology of a virus induced rat osteosarcoma. I. Biological behaviour and histopathology.

Authors:  A A Czitrom; F Langer; A E Gross; E P Urovitz; K P Pritzker
Journal:  Int Orthop       Date:  1980       Impact factor: 3.075

Review 7.  Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.

Authors:  Marc Garcia-Moure; Naiara Martinez-Vélez; Ana Patiño-García; Marta M Alonso
Journal:  J Bone Oncol       Date:  2016-12-14       Impact factor: 4.072

8.  Juxtacortical osteosarcoma of mandible.

Authors:  Sushrut B Vaidya; Srivalli Nadarajan; Jyotsna S Galinde; Alok S Bhardwaj
Journal:  Ann Maxillofac Surg       Date:  2011-07

9.  The metastatic patterns of osteosarcoma.

Authors:  G M Jeffree; C H Price; H A Sissons
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

Review 10.  Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers.

Authors:  Guillaume Anthony Odri; Joëlle Tchicaya-Bouanga; Diane Ji Yun Yoon; Dominique Modrowski
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.